Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

A Negative Feedback Loop Regulates Integrin Inactivation and Promotes Neutrophil Recruitment to Inflammatory Sites.

McCormick B, Craig HE, Chu JY, Carlin LM, Canel M, Wollweber F, Toivakka M, Michael M, Astier AL, Norton L, Lilja J, Felton JM, Sasaki T, Ivaska J, Hers I, Dransfield I, Rossi AG, Vermeren S.

J Immunol. 2019 Sep 15;203(6):1579-1588. doi: 10.4049/jimmunol.1900443. Epub 2019 Aug 19.

2.

SORLA regulates endosomal trafficking and oncogenic fitness of HER2.

Pietilä M, Sahgal P, Peuhu E, Jäntti NZ, Paatero I, Närvä E, Al-Akhrass H, Lilja J, Georgiadou M, Andersen OM, Padzik A, Sihto H, Joensuu H, Blomqvist M, Saarinen I, Boström PJ, Taimen P, Ivaska J.

Nat Commun. 2019 May 28;10(1):2340. doi: 10.1038/s41467-019-10275-0.

3.

Clinical impact of [18F]flutemetamol PET among memory clinic patients with an unclear diagnosis.

Leuzy A, Savitcheva I, Chiotis K, Lilja J, Andersen P, Bogdanovic N, Jelic V, Nordberg A.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1276-1286. doi: 10.1007/s00259-019-04297-5. Epub 2019 Mar 26.

4.

Z-score maps from low-dose 18F-FDG PET of the brain in neurodegenerative dementia.

Fällmar D, Lilja J, Danfors T, Kilander L, Iyer V, Lubberink M, Larsson EM, Sörensen J.

Am J Nucl Med Mol Imaging. 2018 Aug 20;8(4):239-246. eCollection 2018.

5.

Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial.

Frumovitz M, Plante M, Lee PS, Sandadi S, Lilja JF, Escobar PF, Gien LT, Urbauer DL, Abu-Rustum NR.

Lancet Oncol. 2018 Oct;19(10):1394-1403. doi: 10.1016/S1470-2045(18)30448-0. Epub 2018 Aug 22.

PMID:
30143441
6.

Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition.

Thal DR, Beach TG, Zanette M, Lilja J, Heurling K, Chakrabarty A, Ismail A, Farrar G, Buckley C, Smith APL.

Acta Neuropathol. 2018 Oct;136(4):557-567. doi: 10.1007/s00401-018-1897-9. Epub 2018 Aug 19.

7.

Integrin activity in neuronal connectivity.

Lilja J, Ivaska J.

J Cell Sci. 2018 Jun 15;131(12). pii: jcs212803. doi: 10.1242/jcs.212803. Review.

8.

Spatial normalization of [18F]flutemetamol PET images utilizing an adaptive principal components template.

Lilja J, Leuzy A, Chiotis K, Savitcheva I, Sörensen J, Nordberg A.

J Nucl Med. 2018 Jun 14. pii: jnumed.118.207811. doi: 10.2967/jnumed.118.207811. [Epub ahead of print]

9.

Using xCELLigence RTCA Instrument to Measure Cell Adhesion.

Hamidi H, Lilja J, Ivaska J.

Bio Protoc. 2017 Dec 20;7(24). pii: e2646. doi: 10.21769/BioProtoc.2646.

10.

Arterial spin labeling-based Z-maps have high specificity and positive predictive value for neurodegenerative dementia compared to FDG-PET.

Fällmar D, Haller S, Lilja J, Danfors T, Kilander L, Tolboom N, Egger K, Kellner E, Croon PM, Verfaillie SCJ, van Berckel BNM, Ossenkoppele R, Barkhof F, Larsson EM.

Eur Radiol. 2017 Oct;27(10):4237-4246. doi: 10.1007/s00330-017-4784-1. Epub 2017 Apr 3.

11.

AMPK negatively regulates tensin-dependent integrin activity.

Georgiadou M, Lilja J, Jacquemet G, Guzmán C, Rafaeva M, Alibert C, Yan Y, Sahgal P, Lerche M, Manneville JB, Mäkelä TP, Ivaska J.

J Cell Biol. 2017 Apr 3;216(4):1107-1121. doi: 10.1083/jcb.201609066. Epub 2017 Mar 13.

12.

SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras.

Lilja J, Zacharchenko T, Georgiadou M, Jacquemet G, De Franceschi N, Peuhu E, Hamidi H, Pouwels J, Martens V, Nia FH, Beifuss M, Boeckers T, Kreienkamp HJ, Barsukov IL, Ivaska J.

Nat Cell Biol. 2017 Apr;19(4):292-305. doi: 10.1038/ncb3487. Epub 2017 Mar 6.

13.

A Scandcleft randomised trials of primary surgery for unilateral cleft lip and palate: 1. Planning and management.

Semb G, Enemark H, Friede H, Paulin G, Lilja J, Rautio J, Andersen M, Åbyholm F, Lohmander A, Shaw W, Mølsted K, Heliövaara A, Bolund S, Hukki J, Vindenes H, Davenport P, Arctander K, Larson O, Berggren A, Whitby D, Leonard A, Neovius E, Elander A, Willadsen E, Bannister RP, Bradbury E, Henningsson G, Persson C, Eyres P, Emborg B, Kisling-Møller M, Küseler A, Granhof Black B, Schöps A, Bau A, Boers M, Andersen HS, Jeppesen K, Marxen D, Paaso M, Hölttä E, Alaluusua S, Turunen L, Humerinta K, Elfving-Little U, Tørdal IB, Kjøll L, Aukner R, Hide Ø, Feragen KB, Rønning E, Skaare P, Brinck E, Semmingsen AM, Lindberg N, Bowden M, Davies J, Mooney J, Bellardie H, Schofield N, Nyberg J, Lundberg M, Karsten AL, Larson M, Holmefjord A, Reisæter S, Pedersen NH, Rasmussen T, Tindlund R, Sæle P, Blomhoff R, Jacobsen G, Havstam C, Rizell S, Enocson L, Hagberg C, Najar Chalien M, Paganini A, Lundeborg I, Marcusson A, Mjönes AB, Gustavsson A, Hayden C, McAleer E, Slevan E, Gregg T, Worthington H.

J Plast Surg Hand Surg. 2017 Feb;51(1):2-13. doi: 10.1080/2000656X.2016.1263202. Review. Erratum in: J Plast Surg Hand Surg. 2017 Apr;51(2):158.

PMID:
28218559
14.

Scandcleft randomised trials of primary surgery for unilateral cleft lip and palate: 2. Surgical results.

Rautio J, Andersen M, Bolund S, Hukki J, Vindenes H, Davenport P, Arctander K, Larson O, Berggren A, Åbyholm F, Whitby D, Leonard A, Lilja J, Neovius E, Elander A, Heliövaara A, Eyres P, Semb G.

J Plast Surg Hand Surg. 2017 Feb;51(1):14-20. doi: 10.1080/2000656X.2016.1254646. Review.

PMID:
28218552
15.

Validation of true low-dose 18F-FDG PET of the brain.

Fällmar D, Lilja J, Kilander L, Danfors T, Lubberink M, Larsson EM, Sörensen J.

Am J Nucl Med Mol Imaging. 2016 Sep 22;6(5):269-276. eCollection 2016.

16.

Isolated cleft palate requires different surgical protocols depending on cleft type.

Elander A, Persson C, Lilja J, Mark H.

J Plast Surg Hand Surg. 2017 Aug;51(4):228-234. doi: 10.1080/2000656X.2016.1235579. Epub 2016 Oct 18.

PMID:
27750489
17.

Tumor promoter PMA enhances kindlin-2 and decreases vimentin recruitment into cell adhesion sites.

Salmela M, Rappu P, Lilja J, Niskanen H, Taipalus E, Jokinen J, Heino J.

Int J Biochem Cell Biol. 2016 Sep;78:22-30. doi: 10.1016/j.biocel.2016.06.017. Epub 2016 Jun 29.

PMID:
27373681
18.

Mindfulness-based cognitive therapy is effective as relapse prevention for patients with recurrent depression in Scandinavian primary health care.

Lilja JL, Zelleroth C, Axberg U, Norlander T.

Scand J Psychol. 2016 Oct;57(5):464-72. doi: 10.1111/sjop.12302. Epub 2016 Jun 30. Erratum in: Scand J Psychol. 2016 Dec;57(6):621.

PMID:
27358165
19.

Visualization and Quantification of 3-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET Using Variable Depth.

Lilja J, Thurfjell L, Sörensen J.

J Nucl Med. 2016 Jul;57(7):1078-83. doi: 10.2967/jnumed.115.169169. Epub 2016 Feb 16.

20.

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease.

Adamczuk K, Schaeverbeke J, Vanderstichele HM, Lilja J, Nelissen N, Van Laere K, Dupont P, Hilven K, Poesen K, Vandenberghe R.

Alzheimers Res Ther. 2015 Dec 18;7(1):75. doi: 10.1186/s13195-015-0159-5.

21.

Visual Assessment of Brain Perfusion MRI Scans in Dementia: A Pilot Study.

Fällmar D, Lilja J, Velickaite V, Danfors T, Lubberink M, Ahlgren A, van Osch MJ, Kilander L, Larsson EM.

J Neuroimaging. 2016 May;26(3):324-30. doi: 10.1111/jon.12296. Epub 2015 Sep 16.

PMID:
26376736
22.

Amyloid imaging in cognitively normal older adults: comparison between (18)F-flutemetamol and (11)C-Pittsburgh compound B.

Adamczuk K, Schaeverbeke J, Nelissen N, Neyens V, Vandenbulcke M, Goffin K, Lilja J, Hilven K, Dupont P, Van Laere K, Vandenberghe R.

Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):142-151. doi: 10.1007/s00259-015-3156-9. Epub 2015 Aug 12.

PMID:
26260650
23.

OSBP-related protein 3 (ORP3) coupling with VAMP-associated protein A regulates R-Ras activity.

Weber-Boyvat M, Kentala H, Lilja J, Vihervaara T, Hanninen R, Zhou Y, Peränen J, Nyman TA, Ivaska J, Olkkonen VM.

Exp Cell Res. 2015 Feb 15;331(2):278-91. doi: 10.1016/j.yexcr.2014.10.019. Epub 2014 Oct 29.

PMID:
25447204
24.

Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: concordance with visual image reads.

Thurfjell L, Lilja J, Lundqvist R, Buckley C, Smith A, Vandenberghe R, Sherwin P.

J Nucl Med. 2014 Oct;55(10):1623-8. doi: 10.2967/jnumed.114.142109. Epub 2014 Aug 21.

25.

Vertical maxillary growth after two different surgical protocols in unilateral cleft lip and palate patients.

Bakri S, Rizell S, Lilja J, Mark H.

Cleft Palate Craniofac J. 2014 Nov;51(6):645-50. doi: 10.1597/13-122. Epub 2013 Oct 21.

PMID:
24144162
26.

Chapter 14. Discussion about narrative methods as a strategy for investigating and understanding the use and misuse of alcohol and drugs.

Lilja J, Larsson S, von Braun T, Sjöblom Y.

Subst Use Misuse. 2013 Nov;48(13):1438-46. doi: 10.3109/10826084.2013.815025.

PMID:
24087876
27.

Chapter 4. A self-theoretical perspective on the use-misuse of alcohol and drugs based on qualitative and narrative data.

Larsson S, von Braun T, Lilja J, Sjöblom Y, Hamilton D.

Subst Use Misuse. 2013 Nov;48(13):1317-35. doi: 10.3109/10826084.2013.814982.

PMID:
24087866
28.

Chapter 3. A multidimensional model for narrative analysis of substance use-related dependency.

Larsson S, von Braun T, Lilja J.

Subst Use Misuse. 2013 Nov;48(13):1306-16. doi: 10.3109/10826084.2013.814980.

PMID:
24087865
29.

Chapter 2. General theoretical perspectives of narrative analysis of substance use-related dependency.

Larsson S, Lilja J, von Braun T, Sjöblom Y.

Subst Use Misuse. 2013 Nov;48(13):1294-305. doi: 10.3109/10826084.2013.815537.

PMID:
24087864
30.

Chapter 1. Introduction: using narrative research methods for the analysis of use and misuse of alcohol and drugs.

Larsson S, Lilja J, von Braun T, Sjöblom Y.

Subst Use Misuse. 2013 Nov;48(13):1286-93. doi: 10.3109/10826084.2013.814979. No abstract available.

PMID:
24087863
31.

Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data.

Lundqvist R, Lilja J, Thomas BA, Lötjönen J, Villemagne VL, Rowe CC, Thurfjell L.

J Nucl Med. 2013 Aug;54(8):1472-8. doi: 10.2967/jnumed.112.115006. Epub 2013 Jun 5.

32.

John Lilja on Godlaski and Clark's "Implementation issues in an innovative rural substance misuser treatment program".

Lilja J.

Subst Use Misuse. 2012 Nov-Dec;47(13-14):1451-2. doi: 10.3109/10826084.2012.723543. No abstract available.

PMID:
23186436
33.

Height of the palatal vault after two different surgical procedures: study of the difference in patients with complete unilateral cleft lip and palate.

Bakri S, Rizell S, Saied S, Lilja J, Mark H.

J Plast Surg Hand Surg. 2012 Sep;46(3-4):155-8. doi: 10.3109/2000656X.2012.683796. Epub 2012 Jun 14.

PMID:
22694080
34.
35.

Five Facets Mindfulness Questionnaire--reliability and factor structure: a Swedish version.

Lilja JL, Frodi-Lundgren A, Hanse JJ, Josefsson T, Lundh LG, Sköld C, Hansen E, Broberg AG.

Cogn Behav Ther. 2011;40(4):291-303. doi: 10.1080/16506073.2011.580367. Epub 2011 Jul 20.

PMID:
21770845
36.

Long-term, longitudinal follow-up of individuals with UCLP after the Gothenburg primary early veloplasty and delayed hard palate closure protocol: maxillofacial growth outcome.

Friede H, Lilja J, Lohmander A.

Cleft Palate Craniofac J. 2012 Nov;49(6):649-56. doi: 10.1597/10-252. Epub 2011 Jul 8.

PMID:
21740161
37.

Dental arch relationship outcomes in children with complete unilateral cleft lip and palate.

Friede H, Lilja J, Lohmander A.

Cleft Palate Craniofac J. 2012 Jul;49(4):512-3. doi: 10.1597/11-070. Epub 2011 Apr 13. No abstract available.

PMID:
21488713
38.

Self-reported competence of Estonian community pharmacists in relation to herbal products: findings from a health-system in transition.

Volmer D, Lilja J, Hamilton D, Bell JS, Veski P.

Phytother Res. 2011 Mar;25(3):381-6. doi: 10.1002/ptr.3266. Epub 2010 Aug 23.

PMID:
20734324
39.

Major changes to meet the expectations of our international authors and readers.

Elander A, Lilja J.

Scand J Plast Reconstr Surg Hand Surg. 2010 Feb;44(1):3. doi: 10.3109/02844311003760289. No abstract available.

PMID:
20367060
40.

Alveolar bone grafting.

Lilja J.

Indian J Plast Surg. 2009 Oct;42 Suppl:S110-5. doi: 10.4103/0970-0358.57200.

41.

Distribution of mosquitoes in Washington state.

Sames WJ, Duffy A, Maloney FA, Townzen JS, Brauner JM, McHugh CP, Lilja J.

J Am Mosq Control Assoc. 2007 Dec;23(4):442-8.

PMID:
18240520
42.

A sense of coherence and health. Salutogenesis in a societal context: Aland, a special case?

Eriksson M, Lindström B, Lilja J.

J Epidemiol Community Health. 2007 Aug;61(8):684-8.

43.

Identification of proteins released by mammalian cells that mediate DNA internalization through proteoglycan-dependent macropinocytosis.

Wittrup A, Sandgren S, Lilja J, Bratt C, Gustavsson N, Mörgelin M, Belting M.

J Biol Chem. 2007 Sep 21;282(38):27897-904. Epub 2007 Jul 10.

44.

Surfactant-induced TRPV1 activity--a novel mechanism for eye irritation?

Lilja J, Lindegren H, Forsby A.

Toxicol Sci. 2007 Sep;99(1):174-80. Epub 2007 Jun 16.

PMID:
17575321
45.

How cultural factors influence school-based substance use prevention programs.

Lilja J, Giota J, Hamilton D.

Subst Use Misuse. 2007;42(2-3):485-94.

PMID:
17558946
46.
47.

Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam--probes of CYP2C9, CYP1A2, and CYP3A4.

Lilja JJ, Backman JT, Neuvonen PJ.

Clin Pharmacol Ther. 2007 Jun;81(6):833-9. Epub 2007 Mar 28.

PMID:
17392729
48.
49.

HIV-Tat protein transduction domain specifically attenuates growth of polyamine deprived tumor cells.

Mani K, Sandgren S, Lilja J, Cheng F, Svensson K, Persson L, Belting M.

Mol Cancer Ther. 2007 Feb;6(2):782-8.

50.

Supplemental Content

Support Center